/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study
Event: ESC Congress 2023
Topic: Public Health
Session: Innovations in public health and health economics (1)
Long-term risk of cardiovascular side-effects following attention-deficit hyperactivity disorder treatment with sympathomimetic amines
Event: ESC Congress 2023
Topic: Psychiatric Disorders and Heart Disease
Session: Psychiatric and neurologic disease: cardiovascular complications
Usage and risk with phosphodiesterase type 5 inhibitors in male patients with chronic ischemic heart disease on oral organic nitrates
Event: ESC Congress 2021 - The Digital Experience
Topic: Nitrates
Session: Congress committee e-posters choice in pharmacology and pharmacotherapy
Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients with atrial fibrillation on direct-acting oral anticoagulants
Event: ESC Congress 2021 - The Digital Experience
Topic: Anticoagulants
Session: Congress committee e-posters choice in pharmacology and pharmacotherapy
Effect of beta blocker therapy following myocardial infarction in optimally treated patients in the reperfusion era - a Danish, nationwide, and registry-based cohort study
Event: ESC Congress 2020
Topic: Beta-Blockers
Session: Young Investigator Award Session Population Sciences
ESC 365 is supported by
